logo
Plus   Neg
Share
Email

J.C. Penney CEO Jill Soltau To Leave, New Owners Starts Search For New CEO

Department store chain J.C. Penney Co. Inc. Wednesday announced that its new owners Simon Property Group and Brookfield Asset Management have begun a search for a new CEO to replace current leader Jill Soltau.

Soltau will leave the company on December 31. Soltau joined J.C. Penney about two years ago from fabric and craft retailer Joann Stor. She was hired after former CEO Marvin Ellison left to lead Lowe's.

Simon Property Group and Brookfield Asset Management said that they're looking for a new leader "who is focused on modern retail, the consumer experience, and the goal of creating a sustainable and enduring JCPenney."

Early this month, J. C. Penney emerged from bankruptcy after Simon Property Group and Brookfield Asset Management acquired substantially all of its assets.

J.C. Penney had filed for bankruptcy protection in mid-May, citing the impact of unprecedented COVID-19 pandemic on its business. Like majority of retailers across the country, J.C. Penney were forced to close stores for months due to the lockdown restrictions due to the coronavirus pandemic that hurt their sales.

Even before the pandemic outbreak, slowing foot traffic amid the ever-increasing online competition from industry majors and the changing consumer habits had led to many retailers shuttering stores and seeking bankruptcy protection.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration granted emergency use authorization (EUA) for the first and only clinical T cell-based test for patients to detect the unique T-cell signature specific to SARS-CoV-2, the virus that causes COVID-19. The test confirms recent or prior COVID-19 infection. Developed by Adaptive Biotechnologies, T-Detect COVID Test is a next generation sequencing based (NGS) test. AstraZeneca's one batch of Covid vaccine has been suspended by Austrian health authorities following reports of a death and an illness after receiving vaccination, reports said. The issues were reported in the district clinic of Zwettl in Lower Austria province. The Federal Office for Safety in Health Care in the country said the remaining stocks of the affected AstraZeneca/Oxford Covid-19 vaccine DuPont (DD) announced Monday that it has agreed to acquire Laird Performance Materials from with private equity firm Advent International for $2.3 billion. The company will use existing cash balances for the acquisition. The transaction is expected to close in the third quarter of 2021, subject to regulatory...
RELATED NEWS
Follow RTT